Evidence map›Paper›PMID 41595210›Full record

ArticleCancers2026

MRI-Based Delta Necrosis as a Prognostic Marker Following Neoadjuvant Chemotherapy in Soft Tissue Sarcoma.

Harold Bravo Thompson, Priya Chattopadhyay, Ty Subhawong, Malcolm-Christopher Palmer, Sergio Torralbas Fitz, Brooke Crawford, Andrew Rosenberg, H Thomas Temple, Emily Jonczak

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Nitrogen-doped carbon nanodots as a biocompatible FRET donor for caspase-3 detection and chemotherapy response evaluation in osteosarcoma cell lysates.Analytical sciences : the international journal of the Japan Society for Analytical Chemistry · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Harold Bravo ThompsonDepartment of Medicine, University of Miami/Jackson Health System, Miami, Fl 33136, USA.ORCID 0000-0002-1124-9253
Priya ChattopadhyayDepartment of Medicine, University of Miami/Jackson Health System, Miami, Fl 33136, USA.
Ty SubhawongDepartment of Radiology, University of Miami Heath System, Miami, FL 33136, USA.ORCID 0000-0003-0943-1168
Malcolm-Christopher PalmerDepartment of Radiology, University of Miami Heath System, Miami, FL 33136, USA.
Sergio Torralbas FitzDepartment of Orthopedics, Musculoskeletal Oncology Division, University of Miami Heath System, Miami, FL 33136, USA.ORCID 0000-0002-0348-2143
Brooke CrawfordDepartment of Orthopedics, Musculoskeletal Oncology Division, University of Miami Heath System, Miami, FL 33136, USA.
Andrew RosenbergDepartment of Pathology & Laboratory Medicine, University of Miami Heath System, Miami, FL 33136, USA.
H Thomas TempleDepartment of Orthopedics, Musculoskeletal Oncology Division, University of Miami Heath System, Miami, FL 33136, USA.ORCID 0009-0005-7115-073X
Emily JonczakSylvester Comprehensive Cancer Center, Sarcoma Medical Oncology, University of Miami Heath System, Miami, FL 33136, USA.ORCID 0000-0002-0983-8016

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

necrosisneoadjuvant therapyprognostic factorsoft tissue sarcoma

Identifiers

PMID41595210
PMCPMC12838723

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.